Aspirin, one of the world’s oldest and cheapest drugs, has shown remarkable promise in treating colon cancer in people with mutations in a gene that’s thought to play a role in the disease. Among patients with the mutations, those who regularly took aspirin lived longer than those who didn’t, a major study found. Andrew Chan, HMS associate professor of medicine at Massachusetts General Hospital, led the study.
